Angelo Maiolino

Angelo Maiolino

Universidade Federal do Rio de Janeiro - Rajkot / Brazil
Medical and Health Sciences / Hematology
AD Scientific Index ID: 846553
Federal University of Rio de Janeiro UFRJ
person_outline Angelo Maiolino's MOST POPULAR ARTICLES
1-) Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group studySK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ...Leukemia 26 (1), 149-157, 20129122012
2-) Fusarium Infection in Hematopoietic Stem Cell Transplant RecipientsM Nucci, KA Marr, F Queiroz-Telles, CA Martins, P Trabasso, S Costa, ...Clinical Infectious Diseases 38 (9), 1237-1242, 20043362004
3-) Outcome predictors of 84 patients with hematologic malignancies and Fusarium infectionM Nucci, EJ Anaissie, F Queiroz‐Telles, CA Martins, P Trabasso, C Solza, ...Cancer 98 (2), 315-319, 20033112003
4-) Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trialP Moreau, MA Dimopoulos, J Mikhael, K Yong, M Capra, T Facon, ...The Lancet 397 (10292), 2361-2371, 20213132021
5-) Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trialMA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, ...The Lancet 393 (10168), 253-264, 20192592019